These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 2479777)
21. Precursor lesions to prostatic adenocarcinoma. Epstein JI Virchows Arch; 2009 Jan; 454(1):1-16. PubMed ID: 19048290 [TBL] [Abstract][Full Text] [Related]
22. Atypical basal cell hyperplasia of the prostate. Epstein JI; Armas OA Am J Surg Pathol; 1992 Dec; 16(12):1205-14. PubMed ID: 1281386 [TBL] [Abstract][Full Text] [Related]
23. Histomorphological study of prostatic adenocarcinoma and its mimics. Mahapatra QS; Mohanty P; Nanda A; Mohanty L Indian J Pathol Microbiol; 2019; 62(2):251-260. PubMed ID: 30971549 [TBL] [Abstract][Full Text] [Related]
24. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy. Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717 [TBL] [Abstract][Full Text] [Related]
25. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN. He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279 [TBL] [Abstract][Full Text] [Related]
26. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia. Maygarden SJ Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385 [No Abstract] [Full Text] [Related]
27. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Cho JY; Kim SH; Lee SE Eur Urol; 2000 Apr; 37(4):443-8. PubMed ID: 10765075 [TBL] [Abstract][Full Text] [Related]
28. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer". He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613 [TBL] [Abstract][Full Text] [Related]
29. Transrectal ultrasound guided versus digitally directed prostatic biopsy: a comparative study. Resnick MI J Urol; 1988 Apr; 139(4):754-7. PubMed ID: 2451034 [TBL] [Abstract][Full Text] [Related]
32. FNAC and transabdominal ultrasonography in the diagnosis of prostatomegaly. Singh N; Shenoi UD; Raghuveer CV Indian J Pathol Microbiol; 1997 Oct; 40(4):473-9. PubMed ID: 9444858 [TBL] [Abstract][Full Text] [Related]
33. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis of prostate carcinoma on biopsy specimens improved by basal-cell-specific anti-cytokeratin antibody (34 beta E12). Freibauer C Wien Klin Wochenschr; 1998 Sep; 110(17):608-11. PubMed ID: 9816630 [TBL] [Abstract][Full Text] [Related]
35. [Prostatic cancer: role of echography in the diagnosis, evaluation and surveillance]. Fornage B Bull Cancer; 1985; 72(5):442-51. PubMed ID: 2416372 [TBL] [Abstract][Full Text] [Related]
36. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers. Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004 [TBL] [Abstract][Full Text] [Related]
37. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate]. Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979 [TBL] [Abstract][Full Text] [Related]
38. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA]. Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Hoedemaeker RF; Kranse R; Rietbergen JB; Kruger AE; Schröder FH; van der Kwast TH Cancer; 1999 Jan; 85(1):145-52. PubMed ID: 9921986 [TBL] [Abstract][Full Text] [Related]
40. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography]. Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]